Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
34.85INR
5.90 BINR
34.54 BINR
41.39 M
About GLAXO SMITHKLINE P
Sector
CEO
Bhushan Akshikar
Headquarters
Mumbai
Website
Founded
1924
ISIN
INE159A01016
FIGI
BBG000CRN6Y0
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.
Glaxo Smith AnalysisSo, let's analyze Glaxo Smith
On 1M TF it still look bullish as the resistance is getting tested to turn into support.
1W & 1D TF also show bullishness.
If it forms "W" on daily TF and then breaks out, it could potentially reverse from there.
Any candle close below (1900-1870) zone on weekly TF cou
GLAXOOO ...!!!!!CUP & HANDLE pattern break out & retset
on monthly time frame
with volume confirmation.....!!
GLAXO Bullish Longer timeframe Correct time to buyThis stock follow a good up trend in monthly chart, 3month chart also. I have share entry and Stop loss price through chart.
Stock Selection Based on Relative StrengthHello,
Here i will be talking about the process for picking up the stocks based upon the Relative Strength. As this is known to everyone but only few are getting benefitted by applying it in real trading. Most of the gains are made with the stocks having greater RSI. If RSI having > 75 those are th
Example of Stock Basis Relative StrengthStock Beaking out after 2017 at Monthly Time and RSI is around 75
GLAXO / Glaxosmithkline Pharmaceuticals Ltd - 13 Years ConsolidaGLAXO
1) Time Frame - Monthly. Kindly change the time frame to weekly for better understanding.
2) 13 Years of consolidation (Since 2010) broken & Closed strong in WEEKLY time frame.
3) Stock will find its strong resistance / profit booking zone at the primary trendline in the long term.
4) Recomme
Multi year breakoutMulti year breakout after eight years with good volumes.
A good purchase could be when the stock retests the breakout levels.
GlaxoSmithKline start of correction in short term?Glaxo meets has been performing consistently well in past few months time and might pause for a while it seems. It will either be time correction where it will remain in same level range for some time or price correction like a retracement of the price after the impulsive move.
Eventually long ter
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GLAXO is 2430.40 INR — it has decreased by 1.78% in the past 24 hours. Watch GLAXOSMITHKLINE PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GLAXOSMITHKLINE PHARMACEUTICAL stocks are traded under the ticker GLAXO.
GLAXO stock has risen by 18.56% compared to the previous week, the month change is a 24.16% rise, over the last year GLAXOSMITHKLINE PHARMACEUTICAL has showed a 85.80% increase.
We've gathered analysts' opinions on GLAXOSMITHKLINE PHARMACEUTICAL future price: according to them, GLAXO price has a max estimate of 3000.00 INR and a min estimate of 2270.00 INR. Watch GLAXO chart and read a more detailed GLAXOSMITHKLINE PHARMACEUTICAL stock forecast: see what analysts think of GLAXOSMITHKLINE PHARMACEUTICAL and suggest that you do with its stocks.
GLAXO reached its all-time high on Feb 9, 2024 with the price of 2649.95 INR, and its all-time low was 231.05 INR and was reached on Oct 29, 2003. View more price dynamics on GLAXO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLAXO stock is 4.96% volatile and has beta coefficient of 1.56. Track GLAXOSMITHKLINE PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is GLAXOSMITHKLINE PHARMACEUTICAL there?
Today GLAXOSMITHKLINE PHARMACEUTICAL has the market capitalization of 411.72 B, it has decreased by 0.85% over the last week.
Yes, you can track GLAXOSMITHKLINE PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
GLAXOSMITHKLINE PHARMACEUTICAL is going to release the next earnings report on Jul 22, 2024. Keep track of upcoming events with our Earnings Calendar.
GLAXO net income for the last quarter is 1.94 B INR, while the quarter before that showed 457.20 M INR of net income which accounts for 325.37% change. Track more GLAXOSMITHKLINE PHARMACEUTICAL financial stats to get the full picture.
Yes, GLAXO dividends are paid annually. The last dividend per share was 32.00 INR. As of today, Dividend Yield (TTM)% is 1.32%. Tracking GLAXOSMITHKLINE PHARMACEUTICAL dividends might help you take more informed decisions.
GLAXOSMITHKLINE PHARMACEUTICAL dividend yield was 1.65% in 2023, and payout ratio reached 91.87%. The year before the numbers were 2.42% and 88.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLAXOSMITHKLINE PHARMACEUTICAL EBITDA is 9.09 B INR, and current EBITDA margin is 26.31%. See more stats in GLAXOSMITHKLINE PHARMACEUTICAL financial statements.
Like other stocks, GLAXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLAXOSMITHKLINE PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLAXOSMITHKLINE PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLAXOSMITHKLINE PHARMACEUTICAL stock shows the strong buy signal. See more of GLAXOSMITHKLINE PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.